Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01506050 · ClinicalTrials.gov registry record · Phase 1
Bioequivalence Study for Desloratadine OD Tablets 5 mg Under Fasting Condition
A Phase 1 study, sponsored by Dr. Reddy's Laboratories Limited.
- Completed
- Registry status
- Phase 1
- Development phase
- 35
- Enrollment target
NCT01506050: Completed Phase 1 study, sponsored by Dr. Reddy's Laboratories Limited.
NCT01506050 is a Phase 1 study that has completed, run by Dr. Reddy's Laboratories Limited. The registered enrollment target is 35 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (42% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01506050, a Phase 1 study, has completed, sponsored by Dr. Reddy's Laboratories Limited.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 35 participants
- Enrollment target
Study Summary
This is an open label, randomised, single dose, 2-way crossover, comparative bioequivalence study.
Interventions
- DRUG Desloratadine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2006-01 |
| Est. Completion | 2006-02 |
| Phase | Phase 1 |
What the finished NCT01506050 record still lists
NCT01506050 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (42% lower).
The record links to 0 conditions, and to 1 intervention - of which Desloratadine is the first listed.
NCT01506050 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01506050 about?
NCT01506050 is a clinical study titled "Bioequivalence Study for Desloratadine OD Tablets 5 mg Under Fasting Condition". This is an open label, randomised, single dose, 2-way crossover, comparative bioequivalence study.
What is the current status of trial NCT01506050?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 35 participants. The study started on 2006-01. Estimated completion is 2006-02.
What interventions are being tested in trial NCT01506050?
The interventions under investigation include: Desloratadine (DRUG).
Who is sponsoring clinical trial NCT01506050?
This trial is sponsored by Dr. Reddy's Laboratories Limited, which has 52 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01506050's enrollment target sits among peer trials
35 1258th of 2000 higher than 728 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia